|
2010
|
Invention
|
Inhibitors of diacylglycerol o-acyltransferase 1(dgat-1) and uses thereof. The invention pertains... |
|
2008
|
Invention
|
Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7h-1,4-dioxino[2... |
|
2004
|
Invention
|
Retinoid x receptor modulators. The present invention is directed to compounds represented by Str... |
|
2001
|
Invention
|
Regulated activation of cell-membrane receptors by metal-chelating agonists. Invented is a regula... |
|
|
Invention
|
Thrombopoietin mimetics. Invented are non-peptide TPO mimetics. also invented is a method of trea... |
|
|
Invention
|
Thrombopoietin mimetics. Non-peptide TPO mimetics are disclosed, as well as a method of treating ... |
|
1999
|
Invention
|
Thrombopoietin mimetics. Invented are non-peptide TPO mimetics. Also invented is a method of trea... |
|
|
Invention
|
Methods of treating thrombocytopenia. Invented are non-peptide TPO mimetics. Also invented is a m... |
|
1998
|
Invention
|
Novel metal complexes. Invented are metal chelated dimeric cell-surface receptor ligands, pharamc... |
|
|
Invention
|
Novel metal complexes. Invented are zinc chelated G-CSF receptor ligands, pharmaceutical composit... |
|
1995
|
Invention
|
Polypeptide-induced monoclonal receptors to protein ligands. The present invention relates to imm... |
|
1991
|
Invention
|
Heterodimers of retinoid x receptors (rxrs) and other steroid hormone receptors. This invention p... |
